검색
IO Biotech Inc
IOBT관심 목록에 추가
0.048USD
0.0000.00%
종가 04/14, 16:00（ET）시세는 15분 지연됩니다
1.33M시가총액
손실P/E TTM
자세한 내용은 IO Biotech Inc 회사
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
IO Biotech Inc 정보
종목 코드 IOBT
회사 이름IO Biotech Inc
상장일Nov 05, 2021
CEOZocca (Mai-Britt)
직원 수80
유형Ordinary Share
회계 연도 종료Nov 05
주소Ole Maaloes Veh 3
도시COPENHAGEN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Denmark
우편 번호2200
전화4570702980
웹사이트https://www.iobiotech.com/
종목 코드 IOBT
상장일Nov 05, 2021
CEOZocca (Mai-Britt)
IO Biotech Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Mr. David V. Smith
Mr. David V. Smith
Independent Director
Independent Director
--
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
--
--
Ms. Amy B. Sullivan
Ms. Amy B. Sullivan
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Dr. Qasim Ahmad, M.D.
Dr. Qasim Ahmad, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Wed, Feb 25
마지막 업데이트: Wed, Feb 25
주주
주주 유형
주주
주주
비율
Lundbeckfond Ventures
19.39%
Kurma Partners SA
9.48%
Chernett (Jorey)
6.31%
Point72 Asset Management, L.P.
5.60%
Ikarian Capital LLC
1.93%
기타
57.29%
주주
주주
비율
Lundbeckfond Ventures
19.39%
Kurma Partners SA
9.48%
Chernett (Jorey)
6.31%
Point72 Asset Management, L.P.
5.60%
Ikarian Capital LLC
1.93%
기타
57.29%
주주 유형
주주
비율
Venture Capital
28.89%
Hedge Fund
8.10%
Individual Investor
6.63%
Investment Advisor
2.84%
Investment Advisor/Hedge Fund
1.31%
Research Firm
1.29%
기타
50.94%
기관 주식 보유
마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
55
33.63M
46.74%
-19.44M
2025Q4
52
34.65M
48.27%
-16.00M
2025Q3
49
42.06M
63.84%
-13.38M
2025Q2
52
43.99M
66.77%
-12.21M
2025Q1
56
44.00M
66.79%
+640.94K
2024Q4
57
44.61M
67.71%
+1.88M
2024Q3
50
48.46M
73.56%
+5.16M
2024Q2
48
51.73M
78.53%
+7.90M
2024Q1
53
52.99M
80.43%
+6.73M
2023Q4
55
54.27M
82.38%
+8.45M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Lundbeckfond Ventures
13.95M
19.39%
--
--
Apr 11, 2025
Kurma Partners SA
6.82M
9.48%
--
--
Apr 11, 2025
Chernett (Jorey)
4.54M
6.31%
+1.07M
+30.67%
Dec 31, 2025
Point72 Asset Management, L.P.
4.03M
5.6%
+4.03M
--
Feb 05, 2026
Ikarian Capital LLC
1.39M
1.93%
-139.33K
-9.13%
Dec 31, 2025
HBM Partners AG
3.94M
5.48%
--
--
Apr 11, 2025
BofA Global Research (US)
799.95K
1.11%
--
--
Dec 31, 2025
Morgan Stanley Smith Barney LLC
539.18K
0.75%
-129.22K
-19.33%
Dec 31, 2025
Beacon Pointe Advisors LLC
506.00K
0.7%
+506.00K
--
Dec 31, 2025
Boothbay Fund Management, LLC
451.85K
0.63%
-139.33K
-23.57%
Dec 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
